Contrast Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Diagnostic Imaging therapeutic area.
Contrast agents are substances applied in medical imaging to increase visibility of internal structures like organs, blood vessels, and other tissues. Before the imaging operation, they are frequently injected into the body or taken orally to boost contrast and enhance the visibility of specific structures. The contrast agents market includes computed tomography (CT) contrast agents, magnetic resonance imaging (MRI) contrast agents and ultrasound contrast agents (microbubbles).
Contrast agents are used in radiology to get clearer visualizations of various medical conditions and pathologies. Within CT, non-ionic iodinated agents are preferred over ionic iodinated agents for most CT procedures. Barium-based agents are generally used for imaging the GI tract. MRI contrast agents can be used for a variety of procedures, while ultrasound contrast agents are currently mainly used for echocardiograms.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with value, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Companies covered - Bayer AG, GE HealthCare Technologies Inc, Guerbet SA, Bracco Imaging SpA, Lantheus Medical Imaging Inc and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Contrast agents are substances applied in medical imaging to increase visibility of internal structures like organs, blood vessels, and other tissues. Before the imaging operation, they are frequently injected into the body or taken orally to boost contrast and enhance the visibility of specific structures. The contrast agents market includes computed tomography (CT) contrast agents, magnetic resonance imaging (MRI) contrast agents and ultrasound contrast agents (microbubbles).
Contrast agents are used in radiology to get clearer visualizations of various medical conditions and pathologies. Within CT, non-ionic iodinated agents are preferred over ionic iodinated agents for most CT procedures. Barium-based agents are generally used for imaging the GI tract. MRI contrast agents can be used for a variety of procedures, while ultrasound contrast agents are currently mainly used for echocardiograms.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with value, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are :
Currently marketed Contrast Agents and evolving competitive landscape :
- Insightful review of the key industry trends.
- Annualized total Contrast Agents market revenue by segment and market outlooks from 2015-2033.
- Market level data on units, average selling prices and market values.
Global, Regional and Country level market specific insights :
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition, The analyst analysts provide unique country specific insights on the market.
- SWOT analysis for Contrast Agents market.
- Competitive dynamics insights and trends provided for Contrast Agents market.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Companies covered - Bayer AG, GE HealthCare Technologies Inc, Guerbet SA, Bracco Imaging SpA, Lantheus Medical Imaging Inc and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for :- CMO executives who must have deep understanding of the Contrast Agents marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to :
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
- Develop business strategies by understanding the trends shaping and driving Contrast Agents market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Contrast Agents market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Contrast Agents market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer AG
- GE HealthCare Technologies Inc
- Guerbet SA
- Bracco Imaging SpA
- Lantheus Medical Imaging Inc